Recap: Harrow Health Q1 Earnings

Harrow Health (NASDAQ:HROW) reported its Q1 earnings results on Thursday, May 11, 2023 at 04:01 PM. Here’s what…

Harrow Health (NASDAQ:HROW) reported its Q1 earnings results on Thursday, May 11, 2023 at 04:01 PM.

Here’s what investors need to know about the announcement.

Earnings

Harrow Health beat estimated earnings by 40.0%, reporting an EPS of $-0.03 versus an estimate of $-0.05.

Revenue was up $3.98 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.19 which was followed by a 6.78% increase in the share price the next day.

Here’s a look at Harrow Health’s past performance:

Quarter Q4 2022 Q3 2022 Q2 2022 Q1 2022
EPS Estimate -0.12 -0.01 -0.03
EPS Actual 0.07 -0.06 0.01 0.03
Revenue Estimate 21.40M 23.15M 22.07M 19.48M
Revenue Actual 20.33M 22.82M 23.32M 22.12M

To track all earnings releases for Harrow Health visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Avanos Medical, Inc. Reports Preliminary Q4 And FY23 Financial Results; Revises Preliminary 2024 Revenue Outlook; Sees Q4 Revenue $170M-$173M Vs $179.27M Est.; FY23 Revenue $670M-$673M Vs $679.27M Est. ; FY24 Revenue $685M-$705M Vs $714.43M Est.

Avanos Medical, Inc. (NYSE:AVNS) today reported selected, unaudited preliminary financial results for the fourth quarter and full-year ended December 31, 2023 and revised its preliminary revenue outlook for

AVNS